InVitae Corp (NASDAQ:NVTA)’s share price traded up 6.6% during mid-day trading on Monday . The stock traded as high as $9.61 and last traded at $9.53, with a volume of 59,011 shares trading hands. The stock had previously closed at $8.94.

Several equities analysts have issued reports on the stock. Benchmark Co. assumed coverage on shares of InVitae Corp in a research note on Thursday, June 30th. They issued a “hold” rating and a $8.50 price objective for the company. JPMorgan Chase & Co. upped their target price on shares of InVitae Corp from $12.00 to $14.00 and gave the company an “overweight” rating in a report on Tuesday, August 9th. Finally, Zacks Investment Research cut shares of InVitae Corp from a “hold” rating to a “sell” rating in a report on Wednesday, August 10th.

The firm’s market capitalization is $305.87 million. The company’s 50 day moving average price is $8.42 and its 200 day moving average price is $8.79.

InVitae Corp (NASDAQ:NVTA) last issued its earnings results on Monday, August 8th. The company reported ($0.77) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.76) by $0.01. The firm had revenue of $5.60 million for the quarter, compared to analyst estimates of $5.81 million. During the same quarter in the previous year, the company posted ($0.76) earnings per share. The company’s revenue for the quarter was up 211.1% on a year-over-year basis. Equities analysts anticipate that InVitae Corp will post ($2.91) EPS for the current fiscal year.

Invitae Corporation (Invitae) utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.